You are here:
Two key factors set the GAVI Alliance apart from other actors in the field of international health aid:
In this section, we explain GAVI’s partnership model and profile the role of each of the Alliance’s members.
The Bill & Melinda Gates Foundation's initial five-year pledge of US$ 750 million in 1999 provided the seed money to launch GAVI.
As a co-founder of GAVI and the UN's specialist agency on global health issues, WHO is a key implementing partner.
As the world's biggest buyer and supplier of vaccines for developing countries, UNICEF has a pivotal role in the GAVI Alliance.
The World Bank brings the expertise of the world's biggest source of development assistance to the Alliance.
Developing countries are the most important part of the Alliance. They apply for support, manage grants and finance immunisation programmes.
Industrialised country governments' experience in overseas development and funding ensure health is prioritised in aid programmes.
CSOs help deliver vaccines to remote communities, implement vaccine programmes and advocate for immunisation.
GAVI aims to make vaccines more affordable for low-income countries by expanding the range of suppliers to include developing country manufacturers.
GAVI harnesses the technical expertise of the IFPMA to ensure new vaccines are available that address the needs of developing countries.
Partnership with the research community allows GAVI to tap in the latest information and thinking from the scientific, medical and product delivery communities.
Over 19 million children, aged under five, remain unimmunised in the world.
More facts...
25 January 2012
Bill Gates hails UK 'commitment' to fight poverty
The Independent
Bill Gates aims for ultimate goal in 30 years
Channel4
23 January 2012
A Cost-Benefit Analysis of Vaccines
The Atlantic
22 January 2012
Nanoparticle trick 'boosts body's vaccine response'
BBC News
21 January 2012
Can a businessmen’s club eradicate polio from the world?
The Economist
17 January 2012
Heart and Soul: For Global Health, Prescriptions of Medicine and Morality
RAND
14 December 2011
India to introduce pentavalent vaccine today
The Hindu
13 December 2011
PATH and Company to Develop Next Generation Pneumococcal Vaccine
Market Watch
18 November 2011
Five-in-one vaccine to be launched in 2 states next month
Times of India
17 November 2011
Vaccines group to buy cervical cancer shot, as long as it's cheap and countries can deliver it
Washington Post
modal window here